News
INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration
Joins INVO Bioscience to accelerate INVOcell's global OB/GYN clinical integration strategySARASOTA, Fla., July 14, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC),...
INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta
INVO Bioscience and established reproductive specialist Dr. Sue Ellen Carpenter, MD of Bloom Fertility today announce their partnership to make INVOcell, an innovative technology that allows early embryo development to take place within the woman's body, more...
INVO Bioscience Appoints Andrea Goren as Chief Financial Officer
SARASOTA, Fla., June 15, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update
Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., May 17, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...
INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., May 11, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture...
INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion
Aggressive go-to-market sales, partnerships, and marketing strategy to bring INVOcell, fertility care that is accessible, inclusive, and affordable to the more than 90% of couples in need of fertility treatment that currently go without care.SARASOTA, Fla., May 10,...
INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors
Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and brand buildingSARASOTA, Fla., April 26, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal...
INVO Bioscience Joins in Supporting RESOLVE: The National Infertility Association During its National Infertility Awareness Week (NIAW)
- RESOLVE is a non-profit action-based, infertility and family building organization who want to see increased access to all family building options- It's estimated that nearly 90% of couples in need of infertility treatment go without careSARASOTA, Fla., April 22,...
INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California
- Approximately one in eight couples are affected by infertility in the United StatesSARASOTA, Fla. and SAN FRANCISCO, April 19, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal...
INVO Bioscience to Present at Tribe Public Event on April 13, 2021
SARASOTA, Fla., April 12, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System,...